Literature DB >> 15338273

First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability.

Hiroyuki Shimada1, Kimiko Shimizu, Sachiyo Mimaki, Tokuki Sakiyama, Tetsuya Mori, Noriko Shimasaki, Jun Yokota, Kei Nakachi, Tsutomu Ohta, Misao Ohki.   

Abstract

The NBS1 gene is strongly linked to several factors involved in genome integrity. Functional disruption of NBS1 could therefore induce genomic instability and carcinogenesis. Four children with acute lymphoblastic leukemia have been reported to be heterozygous for a germline and/or somatic missense mutation in NBS1, leading to the I171V substitution. We screened healthy controls and pediatric patients with hematological malignancies and aplastic anemia (AA) for the presence of I171V. Of the 62 patients, one individual with AA was confirmed to harbor a homozygous I171V mutation. Genetic analysis of NBS1 in this patient and her healthy parents indicated that she inherited the germline I171V mutation from her father and the wild-type allele from her mother, and that the second I171V hit occurred on the wild-type allele early in embryonic development. Furthermore, cytogenetic analysis of lymphoblastic cell lines from the patient indicated a remarkable increase in numerical and structural chromosomal aberrations in the absence of clastogens, suggesting that she potentially carried genomic instability. This is the first report of AA with a homozygous I171V mutation. We hypothesize that NBS1 may play an important role in the pathogenesis of AA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338273     DOI: 10.1007/s00439-004-1155-1

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

Review 1.  The pathophysiology of acquired aplastic anemia.

Authors:  N S Young; J Maciejewski
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

2.  NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain.

Authors:  Junya Kobayashi; Hiroshi Tauchi; Shuichi Sakamoto; Asako Nakamura; Ken-ichi Morishima; Shinya Matsuura; Toshiko Kobayashi; Katsuyuki Tamai; Keiji Tanimoto; Kenshi Komatsu
Journal:  Curr Biol       Date:  2002-10-29       Impact factor: 10.834

3.  Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome.

Authors:  R Varon; C Vissinga; M Platzer; K M Cerosaletti; K H Chrzanowska; K Saar; G Beckmann; E Seemanová; P R Cooper; N J Nowak; M Stumm; C M Weemaes; R A Gatti; R K Wilson; M Digweed; A Rosenthal; K Sperling; P Concannon; A Reis
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

4.  Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer.

Authors:  F Carlomagno; J Chang-Claude; A M Dunning; B A Ponder
Journal:  Genes Chromosomes Cancer       Date:  1999-08       Impact factor: 5.006

5.  Absence of mutations in the NBS1 gene in B-cell malignant lymphoma patients.

Authors:  S Hama; S Matsuura; H Tauchi; J Sawada; C Kato; F Yamasaki; H Yoshioka; K Sugiyama; K Arita; K Kurisu; N Kamada; Y Heike; K Komatsu
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

6.  NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres.

Authors:  G Wu; W H Lee; P L Chen
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

7.  An increased risk for malignant neoplasms in heterozygotes for a syndrome of microcephaly, normal intelligence, growth retardation, remarkable facies, immunodeficiency and chromosomal instability.

Authors:  E Seemanová
Journal:  Mutat Res       Date:  1990-05       Impact factor: 2.433

8.  Interaction of FANCD2 and NBS1 in the DNA damage response.

Authors:  Koji Nakanishi; Toshiyasu Taniguchi; Velvizhi Ranganathan; Helen V New; Lisa A Moreau; Maria Stotsky; Christopher G Mathew; Michael B Kastan; David T Weaver; Alan D D'Andrea
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

9.  DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein.

Authors:  Pietro Pichierri; Dietrich Averbeck; Filippo Rosselli
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

10.  The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.

Authors:  Pietro Pichierri; Filippo Rosselli
Journal:  EMBO J       Date:  2004-02-26       Impact factor: 11.598

View more
  12 in total

1.  Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation.

Authors:  Haeyoung Kim; Dae-Yeon Cho; Doo Ho Choi; Gee Hue Jung; Inkyung Shin; Won Park; Seung Jae Huh; Sung-Won Kim; Sue K Park; Jong Won Lee; Seok Jin Nam; Jeong Eon Lee; Won Ho Gil; Seok Won Kim
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

2.  RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.

Authors:  Katri Heikkinen; Katrin Rapakko; Sanna-Maria Karppinen; Hannele Erkko; Sakari Knuutila; Tuija Lundán; Arto Mannermaa; Anne-Lise Børresen-Dale; Ake Borg; Rosa B Barkardottir; John Petrini; Robert Winqvist
Journal:  Carcinogenesis       Date:  2006-02-12       Impact factor: 4.944

Review 3.  Nijmegen breakage syndrome (NBS).

Authors:  Krystyna H Chrzanowska; Hanna Gregorek; Bożenna Dembowska-Bagińska; Maria A Kalina; Martin Digweed
Journal:  Orphanet J Rare Dis       Date:  2012-02-28       Impact factor: 4.123

4.  NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review.

Authors:  Francesco Berardinelli; Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

5.  Effect of irradiation on DNA synthesis, NBN gene expression and chromosomal stability in cells with NBN mutations.

Authors:  Jerzy Nowak; Bogna Świątek-Kościelna; Ewelina M Kałużna; Jolanta Rembowska; Agnieszka Dzikiewicz-Krawczyk; Mariola Zawada; Danuta Januszkiewicz-Lewandowska
Journal:  Arch Med Sci       Date:  2017-01-25       Impact factor: 3.318

6.  NBS1 Heterozygosity and Cancer Risk.

Authors:  Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

7.  Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.

Authors:  Johanna M Schuetz; Amy C MaCarthur; Stephen Leach; Agnes S Lai; Richard P Gallagher; Joseph M Connors; Randy D Gascoyne; John J Spinelli; Angela R Brooks-Wilson
Journal:  BMC Med Genet       Date:  2009-11-16       Impact factor: 2.103

8.  Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

Authors:  Sylvie Desjardins; Joly Charles Beauparlant; Yvan Labrie; Geneviève Ouellette; Francine Durocher
Journal:  BMC Cancer       Date:  2009-06-12       Impact factor: 4.430

Review 9.  NBS1 and multiple regulations of DNA damage response.

Authors:  Kenshi Komatsu
Journal:  J Radiat Res       Date:  2016-04-10       Impact factor: 2.724

10.  iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors.

Authors:  Dario Melguizo-Sanchis; Yaobo Xu; Dheraj Taheem; Min Yu; Katarzyna Tilgner; Tomas Barta; Katja Gassner; George Anyfantis; Tengfei Wan; Ramu Elango; Sameer Alharthi; Ashraf A El-Harouni; Stefan Przyborski; Soheir Adam; Gabriele Saretzki; Sujith Samarasinghe; Lyle Armstrong; Majlinda Lako
Journal:  Cell Death Dis       Date:  2018-01-26       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.